sulfoxone

Trade name: Diasone

Small moleculeapproved

Approved

Jun 1, 1944

Sulfoxone is a water-soluble sulfone and is a competitive inhibitor of the bacterial enzyme dihydropteroate synthetase. Sulfoxone under the brand name Diasone was used as an antileprosy drug, for treatment of dermatitis herpetiformis, and to treat pulmonary tuberculosis. Presently, usage of diasone has been discontinued. — NCATS

Clinical trial activity

0 trials · 0 clinical orgs · 2 marketing orgs

Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0

Timeline

1940s

  1. Jun 1, 1944

    Earliest FDA Approval

1970s

  1. May 24, 1974

    AbbVie — NDA Secondary Org

Indications

Mechanism of action

Approval history

  • approvedJun 1, 1944

Chemistry & pharmacology

Loading structure…

SMILES

O=S(O)CNc1ccc(S(=O)(=O)c2ccc(NCS(=O)O)cc2)cc1
Mol. weight
404.49 g/mol
Lipinski Ro5
Pass
Rule of 3
No
Chirality
Racemic Mixture
Inorganic
No
Polymer
No
Delivery
Oral
Availability
Discontinued

Oral

Yes

Parenteral

No

Topical

No

Sources

Also known as

  • aldapsone
  • aldesulfone
  • aldesulfone
  • aldesulfone
  • aldesulfone
  • aldesulfone sodium
  • aldesulfone sodium
  • aldesulfone sodium
  • aldesulfone sodium
  • aldesulfone sodium
  • aldesulfon sodium
  • aldesulphone
  • aldesulphone
  • diasone
  • diasone
  • diasone
  • diasone
  • diasone sodium
  • diasone sodium
  • diasone sodium
  • sodium aldesulphone
  • sodium sulfoxone
  • sodium sulfoxone
  • sodium sulfoxone
  • sulfoxone
  • sulfoxone
  • sulfoxone
  • sulfoxone
  • sulfoxone
  • sulfoxone
  • sulfoxone, disodium salt
  • sulfoxone sodium
  • sulfoxone sodium
  • sulfoxone sodium
  • sulfoxone sodium
  • sulfoxone sodium
  • sulfoxone sodium

Organizations

Marketing (2)

OrganizationOrg typeRelationshipDate
AbbVieFor profitNDA2May 24, 1974
AbbottFor profitNDA